Abstract:In this review, several common types of RNA modifications are reviewed, and the role of regulatory factors related to these modifications in cancer progression is discussed. Finally, the latest advances in small molecule inhibitors of these regulatory factors are especially reviewed. RNA methylation is widespread in nature. Abnormal expression of proteins associated with RNA methylation is strongly associated with a number of human diseases including cancer. Increasing evidence suggests that targeting RNA methylation holds promise for cancer treatment. This review specifically describes several common RNA modifications, such as the relatively well‐studied N6‐methyladenosine, as well as 5‐methylcytosine and pseudouridine (Ψ). The regulatory factors involved in these modifications and their roles in RNA are also comprehensively discussed. We summarise the diverse regulatory functions of these modifications across different types of RNAs. Furthermore, we elucidate the structural characteristics of these modifications along with the development of specific inhibitors targeting them. Additionally, recent advancements in small molecule inhibitors targeting RNA modifications are presented to underscore their immense potential and clinical significance in enhancing therapeutic efficacy against cancer. Key Points In this paper, several important types of RNA modifications and their related regulatory factors are systematically summarised. Several regulatory factors related to RNA modification types were associated with cancer progression, and their relationships with cancer cell migration, invasion, drug resistance and immune environment were summarised. In this paper, the inhibitors targeting different regulators that have been proposed in recent studies are summarised in detail, which is of great significance for the development of RNA modification regulators and cancer treatment in the future.

Influence of RNA Methylation on Cancerous Cells: A Prospective Approach for Alteration of In Vivo Cellular Composition

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Critical Roles and Clinical Perspectives of RNA Methylation in Cancer

Role of Main RNA Modifications in Cancer: N6-methyladenosine, 5-Methylcytosine, and Pseudouridine

Emerging Roles of RNA Methylation in Gastrointestinal Cancers

The role of RNA methylation in tumor immunity and its potential in immunotherapy

RNA methylation and breast cancer: insights into m6A, m7G and m5C

RNA methylation and cancer treatment

The Critical Role of RNA m6A Methylation in Cancer

Non-coding RNA Methylation Modifications in Hepatocellular Carcinoma: Interactions and Potential Implications

The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance

Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus

RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy

Advances in RNA Cytosine-5 Methylation: Detection, Regulatory Mechanisms, Biological Functions and Links to Cancer

Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer

Roles of RNA Methylation on Tumor Immunity and Clinical Implications

RNA methylations in human cancers

Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies

Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy

Novel insights on m 6 A RNA methylation in tumorigenesis: a double-edged sword

Aberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer